FINDINGS OF SCIENTIFIC MISCONDUCT

NIH GUIDE, Volume 24, Number 25, July 14, 1995



P.T. 34



Keywords:

  Ethics/Values in Science & Technol 

  Grants Administration/Policy+ 



Department of Health and Human Services



Notice is hereby given that the Office of Research Integrity (ORI)

has made final findings of scientific misconduct in the following

cases:



Gloria Clayton, R.N., Ed.D., Medical College of Georgia:  The

Division of Research Investigations (DRI) of the Office of Research

Integrity (ORI) reviewed an investigation report, forwarded by the

Medical College of Georgia, into possible scientific misconduct on

the part of Gloria Clayton, R.N., Ed.D., Professor of Adult Nursing

at the Medical College of Georgia.  ORI found that Dr. Clayton

fabricated the existence of subjects and associated data under a

subcontract with the Gerontology Center at the University of Georgia

for research entitled "Adaptation and Mental Health of the Oldest

Old," supported by the National Institute of Mental Health.  Dr.

Clayton, who has admitted this fabrication, has accepted the ORI

findings and agreed to a Voluntary Exclusion Agreement.  Under the

Agreement, Dr. Clayton is not eligible to apply for or receive any

Federal grant or contract funds or to serve on any Public Health

Service Advisory Committee, Board or peer review committee for a

three-year period beginning May 25, 1995.  In addition, Dr. Clayton

has agreed to cooperate with the University of Georgia and the

Medical College of Georgia in the submission of letters of correction

to appropriate journals for publications shown to contain the

fabricated data.



Barbara Jones, St. Mary's Hospital, Montreal:  The Office of Research

Integrity (ORI) conducted an investigation into possible scientific

misconduct on the part of Ms. Barbara Jones while a data coordinator

at St. Mary's Hospital, Montreal, Quebec.  ORI concluded that Ms.

Jones committed scientific misconduct by falsifying and fabricating

the dates of tests or examinations required prior to study entry for

two women entered on the Breast Cancer Prevention Trial (BCPT).  The

BCPT is coordinated by the National Surgical Adjuvant Breast and

Bowel Project (NSABP) and supported by the National Cancer Institute

and the National Heart, Lung, and Blood Institute.  Because the BCPT

is still in progress, no conclusions or results have been published

and no clinical recommendations have been based on the results of the

study.



Ms. Jones did not contest the ORI findings or administrative actions

which require that, for a period of three years, any institution

which proposes Ms. Jones' participation in PHS-supported research

must submit a supervisory plan designed to ensure the scientific

integrity of her contribution.  Ms. Jones is also prohibited from

serving in any advisory capacity to the PHS for a period of three

years.



Farooq A. Siddiqui, Ph.D., Roswell Park Cancer Institute:  The

Division of Research Investigations (DRI) of the Office of Research

Integrity (ORI) completed an investigation into possible scientific

misconduct on the part of Dr. Siddiqui while he was an employee of

Roswell Park Memorial Institute.  ORI finds that Dr. Siddiqui

committed scientific misconduct by misrepresenting data in a

published article.  The research was supported by a grant award from

the National Cancer Institute, National Institutes of Health, Public

Health Service (PHS).



Dr. Siddiqui agreed not to appeal the misconduct finding as part of a

Voluntary Settlement Agreement under which, for a period of two

years, he will not apply as a principal or coprincipal investigator

in any nonprocurement transactions (grants and cooperative

agreements) or as a principal or coprincipal in any contract or

subcontract with the United States Government.  Dr. Siddiqui also is

prohibited from serving on any Public Health Service advisory

committee, board, and/or peer review committee for a period of two

years.  Also, for a two-year period the institution where he is

employed will supervise his performance of work on any covered

transaction including a periodic review of primary data, and certify

the accuracy of any such data used in any United States Government

Public Health Service grant application, contract proposal, or which

is otherwise publicly reported.  He has agreed to submit a letter to

the journal Biochemica et Biophysica Acta (BBA) to retract the

article entitled "Purification and Immunological Characterization of

DNA Polymerase-alpha from Human Acute Lymphoblastic Leukemia Cells"

(BBA, 745:154-161, 1983).



INQUIRIES



For further information, contact:



Director

Division of Research Investigations

Office of Research Integrity

5515 Security Lane, Suite 700

Rockville, MD  20852

Telephone:  (301) 443-5330



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)